Miguel L. Pato

Miguel L. Pato

Auto-generated profile, based on publicly available information

Miguel L. Pato

Epigenetic Therapies Group, Experimental and Clinical Hematology Program, Josep Carreras Leukaemia Research Institute, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 March 2020 in Scientific Data
Verified
Journal Article
Open access
PDF file
JMJoan Mas-Lloret
Joan Mas-Lloret
MOMireia Obón-Santacana
Mireia Obón-Santacana
GIGemma Ibáñez-Sanz
Gemma Ibáñez-Sanz
EGElisabet Guinó
Elisabet Guinó
MPMiguel L. Pato
Miguel L. Pato
VPVille Pimenoff
Ville Pimenoff
The gut microbiome has a fundamental role in human health and disease. However, studying the complex structure and function of the gut microbiome using next generation sequencing is challenging and prone to reproducibility problems. Here, we obtained cross-sectional colon biopsies and faecal samples from nine participants in our COLSCREEN study and sequenced them in high coverage using Illumina pair-end shotgun (for faecal samples) and IonTorrent 16S (for paired feces and colon biopsies) technologies. The metagenomes consisted of between 47 and 92 million reads per sample and the targeted sequencing covered more than 300 k reads per sample across seven hypervariable regions of the 16S gene. Our data is freely available and coupled with code for the presented metagenomic analysis using up-to-date bioinformatics algorithms. These results will add up to the informed insights into designing comprehensive microbiome analysis and also provide data for further testing for unambiguous gut microbiome analysis.

18 February 2021 in Blood
Verified
Journal Article
Open access
PDF file
RERosaura Esteve-Puig
Rosaura Esteve-Puig
FCFina Climent
Fina Climent
DPDavid Piñeyro
David Piñeyro
EDEva Domingo-Domenech
Eva Domingo-Domenech
VDVerónica Dávalos
Verónica Dávalos
MEManel Esteller
Manel Esteller

18 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MBMaria Berdasco
Maria Berdasco
AGAntonio Gómez
Antonio Gómez
MRMarcos J. Rubio
Marcos J. Rubio
JCJaume Catalá-Mora
Jaume Catalá-Mora
Vicente Zanon-MorenoVicente Zanon-Moreno
Vicente Zanon-Moreno
MEManel Esteller
Manel Esteller
This work provides a comprehensive CpG methylation landscape of the different layers of the human eye that unveils the gene networks associated with their biological functions and how these are disrupted in common visual disorders. Herein, we firstly determined the role of CpG methylation in the regulation of ocular tissue-specification and described hypermethylation of retinal transcription factors (i.e., PAX6, RAX, SIX6) in a tissue-dependent manner. Second, we have characterized the DNA methylome of visual disorders linked to internal and external environmental factors. Main conclusions allow certifying that crucial pathways related to Wnt-MAPK signaling pathways or neuroinflammation are epigenetically controlled in the fibrotic disorders involved in retinal detachment, but results also reinforced the contribution of neurovascularization (ETS1, HES5, PRDM16) in diabetic retinopathy. Finally, we had studied the methylome in the most frequent intraocular tumors in adults and children (uveal melanoma and retinoblastoma, respectively). We observed that hypermethylation of tumor suppressor genes is a frequent event in ocular tumors, but also unmethylation is associated with tumorogenesis. Interestingly, unmethylation of the proto-oncogen RAB31 was a predictor of metastasis risk in uveal melanoma. Loss of methylation of the oncogenic mir-17-92 cluster was detected in primary tissues but also in blood from patients.

1 December 2012 in The American Journal of Pathology
Verified
Journal Article
Open access
MBMaría Berdasco
María Berdasco
CMConsolación Melguizo
Consolación Melguizo
JPJose Prados
Jose Prados
AGAntonio Gómez
Antonio Gómez
MAMiguel Alaminos
Miguel Alaminos
MEManel Esteller
Manel Esteller
Adult stem cells have an enormous potential for clinical use in regenerative medicine that avoids many of the drawbacks characteristic of embryonic stem cells and induced pluripotent stem cells. In this context, easily obtainable human adipose-derived stem cells offer an interesting option for future strategies in regenerative medicine. However, little is known about their repertoire of differentiation capacities, how closely they resemble the target primary tissues, and the potential safety issues associated with their use. DNA methylation is one of the most widely recognized epigenetic factors involved in cellular identity, prompting us to consider how the analyses of 27,578 CpG sites in the genome of these cells under different conditions reflect their different natural history. We show that human adipose-derived stem cells generate myogenic and osteogenic lineages that share much of the DNA methylation landscape characteristic of primary myocytes and osteocytes. Most important, adult stem cells and in vitro-generated myocytes and osteocytes display a significantly different DNA methylome from that observed in transformed cells from these tissue types, such as rhabdomyosarcoma and osteosarcoma. These results suggest that the plasticity of the DNA methylation patterns plays an important role in lineage commitment of adult stem cells and that it could be used for clinical purposes as a biomarker of efficient and safely differentiated cells.

30 May 2024 in Blood Advances
Verified
Journal Article
Open access
PDF file
JHJames S. Heald
James S. Heald
ALAleix Méndez López
Aleix Méndez López
MPMiguel L. Pato
Miguel L. Pato
NRNeus Ruiz-Xivillé
Neus Ruiz-Xivillé
MCMarta Cabezón
Marta Cabezón
MBMaria Berdasco
Maria Berdasco
James S Heald, Aleix Méndez López, Miguel L Pato, Neus Ruiz-Xiville, Marta Cabezón, Lurdes Zamora, Susana Vives, Rosa Coll Jorda, Clara Maluquer Artigal, I James S Heald, Aleix Méndez López, Miguel L Pato, Neus Ruiz-Xiville, Marta Cabezón, Lurdes Zamora, Susana Vives, Rosa Coll Jorda, Clara Maluquer Artigal, I

7 November 2024 in American Journal of Transplantation
Verified
Journal Article
Open access
JCJosep M. Cruzado
Josep M. Cruzado
ASAnna Sola
Anna Sola
MPMiguel L. Pato
Miguel L. Pato
AMAnna Manonelles
Anna Manonelles
CVCristian Varela
Cristian Varela
MBMaria Berdasco
Maria Berdasco